Based on recent data, Structure Therapeutics Inc. (GPCR) shows an Average True Range (ATR) of 4.57 and an Enterprise Value of 1.57B. Its average trading volume over the past 3 months is 1.47M, indicating liquidity. These fundamental metrics provide insight into GPCR's underlying financial health and market activity.
| ATR | 4.57 |
| Enterprise Value | 1.57B |
| Avg Vol (3 Months) | 1.47M |
| Avg Vol (10 Days) | 1.05M |
Structure Therapeutics Inc. (GPCR) technical indicators as of January 11, 2026: the SMA 20 is 3.83%, SMA 50 at 40.22%, and SMA 200 at 139.73%. The RSI 14 value is 63.13, suggesting its current momentum. These technical analysis signals help assess GPCR's price trends and potential future movements.
| SMA 20 | 3.83% |
| SMA 50 | 40.22% |
| SMA 200 | 139.73% |
| RSI 14 | 63.13 |
Structure Therapeutics Inc. (GPCR) stock performance overview as of January 11, 2026: The 52-week high is $94.9 (currently -27.7% below), and the 52-week low is $13.22 (currently 418.99% above). Over the past year, GPCR's performance is 137.6%, compared to the S&P 500's 12.34% change.
| 52-Week High | 94.9 |
| 52-Week High Chg | -27.70% |
| 52-Week Low | 13.22 |
| 52-Week Low Chg | +418.99% |
| S&P 500 52-Week Chg | 12.34% |
According to market data, Structure Therapeutics Inc. (GPCR) stock's recent performance metrics show that over the last month, GPCR is 93.81%, with a Year-to-Date (YTD) performance of -3.7%. Over the past year, the stock has seen a 137.6% change. These figures summarize GPCR's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 69.78 | 72.39 | 94.9 | 94.9 | 94.9 | 70.4 |
| Low | 61.99 | 58.84 | 25.59 | 15.8 | 13.22 | 61.99 |
| Performance | -3.70% | +93.81% | +135.68% | +250.68% | +137.60% | -3.70% |
According to current financial data, GPCR stock's P/E (TTM) ratio is -7.35, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for GPCR, including P/S (2217.25), P/B (1.70), and P/FCF (-24.05), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | GPCR | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -7.35 | -1.24 | -5.16 | 32.59 |
| P/S (TTM) | 2217.25 | 3.71 | 465.9 | 5.98 |
| P/B (TTM) | 1.7 | 0.19 | -335.2 | 6.24 |
| P/FCF (TTM) | -24.05 | -8.98 | -394.53 | 36.55 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep